A transcriptional repressor co-regulatory network governing androgen response in prostate cancers
about
One-Carbon Metabolism in Prostate Cancer: The Role of Androgen SignalingMinireview: Conversing with chromatin: the language of nuclear receptorsAndrogen receptor activation in castration-recurrent prostate cancer: the role of Src-family and Ack1 tyrosine kinasesInterplay between genomic alterations and androgen receptor signaling during prostate cancer development and progressionThe primary microRNA-208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heartIdentification of a Novel Coregulator, SH3YL1, That Interacts With the Androgen Receptor N-Terminus.NIPP1 maintains EZH2 phosphorylation and promoter occupancy at proliferation-related target genes.Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMSIntegrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancerMinireview: The versatile roles of lysine deacetylases in steroid receptor signalingInfluence of oncogenic transcription factors on chromatin conformation and implications in prostate cancer.The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells.Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancerAndrogen receptor functions in prostate cancer development and progressionMolecular pathways and targets in prostate cancerSAMSN1 is highly expressed and associated with a poor survival in glioblastoma multiforme.MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer.The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin.A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variantsThe ETS domain transcription factor ELK1 directs a critical component of growth signaling by the androgen receptor in prostate cancer cellsAndrogen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axisMolecular pathogenesis and progression of prostate cancerMultifaceted role of EZH2 in breast and prostate tumorigenesis: epigenetics and beyond.Class I lysine deacetylases facilitate glucocorticoid-induced transcription.Identification of an AR Mutation-Negative Class of Androgen Insensitivity by Determining Endogenous AR Activity.Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer.The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.Integrated bioinformatics analysis of chromatin regulator EZH2 in regulating mRNA and lncRNA expression by ChIP sequencing and RNA sequencing.Tissue-specific pioneer factors associate with androgen receptor cistromes and transcription programs.The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate CancerTranscriptional network of androgen receptor in prostate cancer progression.Epigenetic modifications in prostate cancer.Role of ChIP-seq in the discovery of transcription factor binding sites, differential gene regulation mechanism, epigenetic marks and beyond.Androgen receptor epigenetics.The oncogene ERG: a key factor in prostate cancer.Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk-associated loci.Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer.The Germ Cell Gene TDRD1 as an ERG Target Gene and a Novel Prostate Cancer Biomarker.Mutations and deletions of PRC2 in prostate cancer.Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
P2860
Q26740548-388105E0-C17D-438D-8ED9-78AD9978A89CQ26829103-DFDA839A-D2A9-43E2-AF62-4F0500710AEDQ26866135-98CF1A26-22AC-456E-A0B3-EC815D4D1EBBQ27022288-0C740379-8D75-4440-A26D-A68E5B07D9C1Q28586308-8E867E48-C555-4289-B919-1B6A5E422DA8Q30009112-9E4C5AC6-D06C-4366-B5B3-C4756408ACCFQ30532831-8666A43A-C1FA-433A-911C-C0E8DFA120B4Q33592489-509AB2F7-A61A-44F6-A38F-1F65EA334108Q33631876-8FFE5C26-5C3C-4021-8088-AA930488794AQ33632070-EEB3C7C4-B03F-4860-AE96-519342748A13Q33675577-9FB302B2-8779-459C-B862-1B93BACA6B25Q33761920-82E9CE92-F5A0-44A1-A8EE-4B63C9F36D03Q33862890-D51787E0-57A5-4B2B-AE20-7EEE98073E8DQ33922393-9240C7EC-0519-4B09-891B-D2E8B4F1735DQ34365632-A09D0351-695E-4425-818B-4B1F3F635A04Q35054111-47FE4D60-9297-4216-A499-B9559542731BQ35656832-4A56F826-B9C0-4DED-B83E-2F8D1A1F6A3DQ36065142-DD6AB1D2-8906-4B9D-9C2A-1AC004BF74F7Q36087132-20F1FB6B-E1AC-4C2C-8897-4A631394D7E7Q36779605-6A3C5E76-341B-4ACA-90B9-027A9C45A288Q36961208-C6EC4151-1D33-44EC-B3E8-108EF8E32F58Q37055715-D1C62159-62A7-47C4-AA4F-B1F51007A3D2Q37089496-040174BC-8BA7-40F4-BE1D-3284664334A9Q37213852-291C3BEF-3F83-47A3-B02B-C5310CCF5E85Q37393262-F0FFFC2C-7821-4F98-ADA4-324D26848DCAQ37660030-669A078E-A224-4538-BCE4-B76811D6BAA4Q37662159-205FA6CC-89E7-4525-B53B-F474507F7BEDQ37697207-74139697-4BA1-46E0-A728-695FCA1890A0Q37707477-CD359107-4992-493E-BF72-BBDDCEBEF3E5Q37729422-2A7A4EC9-F751-47D4-B18E-50549B43B7FCQ38100269-F6537057-0EE8-41C4-9A9C-4DB01C98BAFBQ38261747-2BF2F86D-A27C-444F-8154-94EE611E0B0FQ38285179-76DC5450-B65C-4B52-A829-47B4E5266054Q38314940-6D1F6489-D60E-4777-AB62-289146B658A0Q38444138-05D273D1-8EF2-4DF6-B39A-06722D9ABC15Q38503798-9FF04116-1DC7-4AC0-A9A1-66AEE089C377Q38710470-8D5DD3EB-929B-4680-A143-DEA604CD57F6Q38766041-FA3BF1B6-2754-4A64-818E-8CC2868E69A7Q38783694-E80D6302-DA7E-4D4C-84E3-B55D7D316DF9Q38800435-31517142-34ED-47FE-AE7D-1B12A53E0A7C
P2860
A transcriptional repressor co-regulatory network governing androgen response in prostate cancers
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A transcriptional repressor co ...... n response in prostate cancers
@ast
A transcriptional repressor co ...... n response in prostate cancers
@en
A transcriptional repressor co ...... n response in prostate cancers
@en-gb
A transcriptional repressor co ...... n response in prostate cancers
@nl
type
label
A transcriptional repressor co ...... n response in prostate cancers
@ast
A transcriptional repressor co ...... n response in prostate cancers
@en
A transcriptional repressor co ...... n response in prostate cancers
@en-gb
A transcriptional repressor co ...... n response in prostate cancers
@nl
prefLabel
A transcriptional repressor co ...... n response in prostate cancers
@ast
A transcriptional repressor co ...... n response in prostate cancers
@en
A transcriptional repressor co ...... n response in prostate cancers
@en-gb
A transcriptional repressor co ...... n response in prostate cancers
@nl
P2093
P2860
P3181
P356
P1433
P1476
A transcriptional repressor co ...... n response in prostate cancers
@en
P2093
Cheng Wei Chang
Chong Yang
Edwin Cheung
Kern Rei Chng
Noel Yan Wei Sng
Shu Zhen Hong
Si Kee Tan
P2860
P304
P3181
P356
10.1038/EMBOJ.2012.112
P407
P577
2012-06-13T00:00:00Z